Yamasaki Y - Search Results

1

Portal insulin delivery is superior to peripheral delivery in handling of portally delivered glucose.

Kubota M, Yamasaki Y, Sekiya M, Kubota M, Morishima T, Kishimoto M, Kawamori R, Shichiri M, Kamada T. Kubota M, et al. Among authors: yamasaki y. Metabolism. 1996 Feb;45(2):150-4. doi: 10.1016/s0026-0495(96)90045-1. Metabolism. 1996. PMID: 8596481

2

Normoglycemia per se but not normoinsulinemia is responsible for suppressing endogenous insulin secretion after oral glucose load in NIDDM.

Yamasaki Y, Kawamori R, Bando K, Katsura M, Iwama N, Kubota M, Shichiri M, Kamada T. Yamasaki Y, et al. Diabetes Res Clin Pract. 1992 Feb;15(2):113-9. doi: 10.1016/0168-8227(92)90014-i. Diabetes Res Clin Pract. 1992. PMID: 1563327

3

Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.

Kawamori R, Bando K, Yamasaki Y, Kubota M, Watarai T, Iwama N, Shichiri M, Kamada T. Kawamori R, et al. Among authors: yamasaki y. Diabetes Care. 1989 Nov-Dec;12(10):680-5. doi: 10.2337/diacare.12.10.680. Diabetes Care. 1989. PMID: 2515048

4

Simultaneous evaluation of insulin secretion and action using a model.

Yamasaki Y, Kawamori R, Tohdo R, Nomura M, Kubota M, Kamada T, Shichiri M. Yamasaki Y, et al. Diabetes Res Clin Pract. 1989 Jan 3;6(1):17-25. doi: 10.1016/0168-8227(89)90053-3. Diabetes Res Clin Pract. 1989. PMID: 2649338

5

The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas.

Yagi T, Yamasaki Y, Bando K, Kawamori R, Kamada T, Shichiri M. Yagi T, et al. Among authors: yamasaki y. Med Prog Technol. 1988;13(4):195-201. Med Prog Technol. 1988. PMID: 2972904

6

Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.

Shichiri M, Kawamori R, Goriya Y, Yamasaki Y, Nomura M, Asakawa N, Kubota M, Kamada T. Shichiri M, et al. Among authors: yamasaki y. Life Support Syst. 1985;3 Suppl 1:583-7. Life Support Syst. 1985. PMID: 3916624

7

1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.

Kishimoto M, Yamasaki Y, Kubota M, Arai K, Morishima T, Kawamori R, Kamada T. Kishimoto M, et al. Among authors: yamasaki y. Diabetes Care. 1995 Aug;18(8):1156-9. doi: 10.2337/diacare.18.8.1156. Diabetes Care. 1995. PMID: 7587851 Clinical Trial.

8

Effect of addition of hyaluronic acid to highly concentrated insulin on absorption from the conjunctiva in conscious diabetic dogs.

Nomura M, Kubota MA, Kawamori R, Yamasaki Y, Kamada T, Abe H. Nomura M, et al. Among authors: yamasaki y. J Pharm Pharmacol. 1994 Sep;46(9):768-70. doi: 10.1111/j.2042-7158.1994.tb03900.x. J Pharm Pharmacol. 1994. PMID: 7837049

9

Selective alpha 1-adrenergic inhibition improves decrease glucose disposal in patients with essential hypertension.

Yamasaki Y, Shiba Y, Sekiya M, Tsujino T, Hakui N, Kawamori R, Kamada T. Yamasaki Y, et al. J Hum Hypertens. 1994 Aug;8(8):555-8. J Hum Hypertens. 1994. PMID: 7990080

10

Clinical usefulness of a non-wiping type glucose meter in diabetic patients.

Kishimoto M, Kawamori R, Kubota M, Ikeda M, Morishima T, Yamasaki Y, Kamada T. Kishimoto M, et al. Among authors: yamasaki y. Diabetes Res Clin Pract. 1993 Apr;20(1):47-50. doi: 10.1016/0168-8227(93)90021-v. Diabetes Res Clin Pract. 1993. PMID: 8344128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,496 results

Search Page

Filters